StonvexLoading…
StonvexStonvexStonvexCore line items from ARWR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $829.45M | $3.55M | $240.74M | $243.23M |
Operating Income | $98.35M | $-601.08M | $-205.00M | $-178.51M |
Net Income | $-1.63M | $-599.49M | $-205.28M | $-176.06M |
EPS (Diluted) | $-0.01 | $-5.00 | $-1.92 | $-1.67 |
Total Assets | $1.39B | $1.14B | $765.55M | $691.94M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $226.55M | $102.69M | $110.89M | $108.00M |
Free Cash Flow OCF − CapEx | $156.89M | $-604.32M | $-330.63M | $-188.91M |
Shares Outstanding | 135.70M | 124.38M | 107.31M | 105.96M |